Answers are grounded in this paper and cite their sources.
Compatibility Study Shows Potential Co-Formulation of Gabapentin and Coumarin for Neurological Treatment.
We investigated the interactions of gabapentin and coumarin using UV Spectrophotometric estimation and molecular docking studies. UV-vis spectrophotometry was utilized to design and validate a method for the simultaneous measurement of the two substances. The absorbance maxima for gabapentin (572 nm) and coumarin (274 nm) were found. The method's specificity, accuracy (% recovery from 98-102 %), precision (intra/inter-day % RSD < 2 %), linearity (r2 > 0.99) and sensitivity (LOD < 0.4 µg/mL) were all validated by ICH guidelines. Swiss Dock molecular docking tests indicated that gabapentin (-4.375 kcal/mol) and coumarin (-5.499 kcal/mol) had relatively favourable binding affinities, indicating a moderate interaction with the enzyme binding site. This study concluded that these chemicals may be compatible and potentially co-formulated to treat neurological aspects of disease conditions.
No takes yet. Share an insight, caveat, or question.
Chatterjee et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: